A Grateful Kidney Transplant Patient Meets Care Team for Ice Cream

McKaylea DeLong is a 9-year-old who lives in a small town outside of Syracuse, New York. She developed a rare autoimmune kidney disease in 2021 and was treated at a hospital in Syracuse for several weeks, with some improvement in kidney function, but ultimately, her disease was too far advanced, and medical therapy was not successful. The Mount Sinai Recanati/Miller Transplantation Institute team started following her in 2022, when she was referred for evaluation for a kidney transplant. And she received her new kidney in September 2022.

Two years later, McKaylea was granted her wish from the Make-A-Wish Foundation, when she returned to New York City to “do all the things I couldn’t do when I was here for my transplant.” In addition, she wanted to meet the transplant surgeon who saved her life, and, importantly, share ice cream with him. On August 29, she did just that, meeting Vikram Wadhera, MBBS, and Rafael Khaim, DNP, ANP-BC, FNP-BC, Clinical Senior Operations Manager, Pediatric and Adult Renal Transplant, at Noi Due Gelato on the Upper West Side.

McKaylea DeLong with Rafael Khaim, DNP, ANP-BC, FNP-BC, left, and Vikram Wadhera, MD

McKaylea’s mother is incredibly grateful to Dr. Wadhera, and the “phenomenal” team who cared for McKaylea and supported the family. “From the receptionist to the nutritionist, so many kind and skilled professionals. They blew me out of the water,” she says. “All willing to answer any and all questions and address my concerns.”

She has special praise for Rafael, who she says, “was on the jump from day one” and throughout McKaylea’s journey for a new kidney, including planning the meet-up with Dr. Wadhera. Not only did Rafael make all the arrangements for the ice cream date, but he purchased an American Doll for McKaylea, complete with blonde hair like hers.

Rafael is aware that that everyone on the team can make a lasting impact on patients.

“We all have the potential to change the lives of those we care for, in and out of the hospital, and can shape experiences that will turn into cherished memories forever.”

Mount Sinai Alumni Awards Honor Extraordinary Contributions to Medicine and the Community

Seated from left: Samuel Márquez, PhD, FAAA; Sally Claridge, PhD, ISMMS ’24; Craig L. Katz, MD, MSH ’96; Roopa Kohli-Seth, MD, FCCP, FACP, MSH ’00; Scott Gottlieb, MD, MSSM ’99, MSH ’02; George B. Wanna, MD, MHCM, FACS, MSH ’08; Ebby Elahi, MD, FACS, MSSM ’96, MSH ’00; Talia H. Swartz, MD, PhD, MSSM ’06 ’08, MSH ’10, ’13; Standing from left: Larry Attia, MD, SLR ’93 ’95; Timothy Friedmann, MD, MSH ’23 ’24; Kurian Thomas, MD, SLR ’94; Brendan G. Carr, MD, MA, MS, Chief Executive Officer of the Mount Sinai Health System; Dennis Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; Mark A. Rubin, MD, MSSM ’88, MSH ’89; Rory M.C. Abrams, MD, MSH ’19 ’20; Alexis Colvin, MD, MSSM ’02; Mary O’Sullivan, MD, SLR ’78; Not pictured: Laura P. Gelfman, MD, MPH, MSSM ‘07 ‘14, MSH ’11; Bachir Taouli, MD, MHA.

The Mount Sinai Alumni Awards Ceremony recently celebrated Mount Sinai and St. Luke’s-Roosevelt alumni and students who have made extraordinary contributions to the medical field and to the Mount Sinai community. Fourteen alumni received Alumni Awards.

The event was held Tuesday, September 17, at the New York Academy of Medicine. About 200 faculty, staff, and honored guests in attendance. Click here to read the program and click here to see more photos.

The Alumni Award Recipients are:

The Mount Sinai Alumni Leadership Award: Sally Claridge, PhD, ISMMS ’24

Sally Claridge, PhD, received her PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai. Integrating her laboratory and computational experience, her research focused on developing a functional genomics pipeline for precision oncology in the lab of Benjamin D. Hopkins, PhD.

The Mount Sinai Alumni Leadership Award: Timothy Friedmann, MD, MSH ’23 ‘24

Timothy Friedmann, MD, is a Clinical Instructor in the Department of Emergency Medicine at Icahn Mount Sinai. He is also an Assistant Program Director for the residency program in Emergency Medicine,  Mount Sinai Health System.

St. Luke’s-Roosevelt Distinguished Young Physician of the Year: Rory M.C. Abrams, MD, MSH ’19 ’20

Rory M. C. Abrams, MD, MSH ’19 ’20, is Assistant Professor of Neurology, Mount Sinai Health System, and an attending physician in the Department of Neurology at Mount Sinai West, Mount Sinai Morningside, and The Mount Sinai Hospital.

The Jeffrey T. Laitman, PhD Award for Achievement in Medical Education: Samuel Márquez, PhD, FAAA

Samuel Márquez, PhD, FAAA, is the Co-Discipline Director of Anatomy in the College of Medicine, Director of Gross Anatomy for the School of Health Professions, and Professor in the departments of Cell Biology and Otolaryngology at SUNY Downstate Health Sciences University.

The Mount Sinai Graduate School Alumni Award: Laura P. Gelfman, MD, MPH, MSSM ‘07 ‘14, MSH ‘11

Laura P. Gelfman, MD, MPH, is Vice Chair, Quality and Clinical Innovation, for the Department of Geriatrics and Palliative Medicine, Mount Sinai Heath System, and Professor in the Department of Geriatrics and Palliative Medicine at Icahn Mount Sinai.

The Mount Sinai Master Clinician Award: George B. Wanna, MD, MHCM, FACS, MSH ’08

George B. Wanna, MD, MHCM, FACS, holds dual professorships in Otolaryngology-Head and Neck Surgery and Neurosurgery at Icahn Mount Sinai. He is also Executive Vice Chair of the Department of Otolaryngology-Head and Neck Surgery, the Chief of the Division of Otology-Neuro-Otology and Skull Base Surgery, and the Chair of the New York Eye and Ear Infirmary of Mount Sinai.

The Mount Sinai Alumni Special Recognition Award: Scott Gottlieb, MD, MSSM ’99, MSH ’02

Scott Gottlieb, MD, is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a senior fellow at the American Enterprise Institute for Public Policy Research and a partner at the venture capital firm New Enterprise Associates.

The Mount Sinai Alumni Special Recognition Award: Roopa Kohli-Seth, MD, FCCP, FACP, MSH ’00

Roopa Kohli-Seth, MD, FCCP, FACP, is Director of the Institute for Critical Care Medicine, Mount Sinai Health System, and a Professor in the Department of Surgery at Icahn Mount Sinai.

The Terry Ann Krulwich Physician-Scientist Alumni Award: Talia H. Swartz, MD, PhD, MSSM ’06 ’08, MSH ’10, ’13

Talia H. Swartz, MD, PhD, is Senior Associate Dean for MD-PhD Education, Director of the Medical Scientist Training Program, and Director of Graduate Research and Education at The Center for Antiracism in Practice at Icahn Mount Sinai.

The Dr. Sidney Grossman Distinguished Humanitarian Award: Craig L. Katz, MD, MSH ’96

Craig L. Katz, MD, is a Clinical Professor of Psychiatry, Medical Education, and System Design and Global Health at Icahn Mount Sinai. He is the founding director of the Mount Sinai Program in Global Mental Health.

The J. Lester Gabrilove Award: Bachir Taouli, MD, MHA

Bachir Taouli, MD, MHA, is a Professor of Radiology in the Abdominal Imaging/Body MRI Section of the Department of Diagnostic, Molecular and Interventional Radiology, in addition to the BioMedical Engineering and Imaging Institute at Icahn Mount Sinai.

St. Luke’s-Roosevelt Distinguished Alumni Award: Mary O’Sullivan, MD, SLR ’78

For more than three decades, Mary O’Sullivan, MD, served as Director of the Chest Clinic, the largest medical subspecialty clinic at Mount Sinai Morningside.

St. Luke’s-Roosevelt Distinguished Alumni Award: Kurian Thomas, MD, SLR ’94

Kurian Thomas, MD, is Assistant Professor of Anesthesiology, Perioperative and Pain Medicine at Icahn Mount Sinai and has been at the heart of the Division of Anesthesia at Mount Sinai Morningside (formerly St. Luke’s Hospital) for more than 30 years.

The Saul Horowitz, Jr. Memorial Award: Mark A. Rubin, MD, MSSM ’88, MSH ’89

Mark A. Rubin, MD, is Founding Director of the Bern Center for Precision Medicine and Director of the Department for BioMedical Research at the University of Bern in Switzerland.

Mount Sinai Children’s Center Foundation Annual Benefit Supports Family-Centered Care and Research

The 37th annual Mount Sinai Children’s Center Foundation (CCF) Benefit returns to the Big Apple Circus on Sunday, November 10, under the “Big Top at Lincoln Center.” Click here to purchase tickets.

This is the largest fundraiser for the Foundation and an opportunity to bring together the Mount Sinai community of faculty, staff, families, and friends. Ticket purchases and donations will support every aspect of family-centered care.

The benefit will be a fun-filled family day with a private performance of the Big Apple Circus, activities, gifts for the kids, and complimentary refreshments. Doors open at 3 pm, and the private performance begins at 4 pm. The Big Apple Circus is located in Damrosch Park at Lincoln Center for the Performing Arts.

“This year’s benefit chairs are CCF board members Madi Rothenberg Karpova and Ivan Karpov, and we are so grateful to them for all of their support,” says Lisa M. Satlin, MD, Herbert H. Lehman Professor and System Chair of the Jack and Lucy Clark Department of Pediatrics.

Proceeds from this year’s benefit will support essential renovations at Mount Sinai Kravis Children’s Hospital, therapeutic programs to alleviate stress and anxiety during a child’s hospital stay, and innovative research to advance pediatric medicine.

The event will also honor the Food Allergy Treatment and Research Center at the Elliot and Roslyn Jaffe Food Allergy Institute and the surgeons of Mount Sinai Kravis Children’s Hospital.

“The tremendous support that the Mount Sinai Kravis Children’s Hospital and the Jack and Lucy Clark Department of Pediatrics receive from the Mount Sinai Children’s Center Foundation and our annual benefit helps ensure our ability to provide top-quality care for our youngest patients. It helps us extensively in our mission of delivering innovative care, research, and education that equitably advances health for children and families,” says Dr. Satlin. “We are deeply grateful for the efforts of the Mount Sinai Children’s Center Foundation.”

Learn more about the Mount Sinai Children’s Center Foundation. (link to https://www.mountsinai.org/locations/kravis-childrens/services/child-family-support/childrens-center-foundation)

Groundbreaking Technology Drives Innovations and Improved Outcomes in Spine Surgery at Mount Sinai West

Mount Sinai Spine is at the forefront of innovation in spine surgery, combining leading-edge technologies like machine-vision navigation and augmented reality (AR) with a strong commitment to minimally invasive approaches. These advancements enhance surgical precision, improve patient safety, and reduce recovery times.

By integrating AI algorithms and robotics, Mount Sinai Spine is paving the way for a new era in spinal care, where each procedure is tailored to you, ensuring exceptional outcomes and setting the stage for future breakthroughs in the field.

Greater Precision With Machine-Vision Navigation

Machine-vision navigation utilizes visible light, eliminating the need for intraoperative radiation. This approach eliminates radiation exposure for patients. Unlike traditional methods that require preoperative computerized tomography (CT) scans and intraoperative fluoroscopy, the system at Mount Sinai Spine relies on camera-based technology and machine-vision algorithms.

The benefits are significant: zero radiation exposure, rapid image acquisition in under 30 seconds, and exceptional accuracy across every level of the spine.

At Mount Sinai Spine, the integration of machine-vision navigation has revolutionized spine surgery.

Jeremy M. Steinberger, MD

Jeremy M. Steinberger, MD, Director of Minimally Invasive Spine Surgery and Associate Professor of Neurosurgery, Orthopedics, and Rehabilitation and Human Performance, says this technology significantly enhances surgical precision, which is essential for preventing nerve damage and optimizing screw placement.

“By tailoring care to your unique anatomy, this advanced approach improves safety, streamlines surgical workflows, reduces procedure time, and ultimately enhances patient outcomes,” he says.

Augmented Reality Enhances Surgical Detailed Visualization

Augmented reality is transforming spine surgery, making procedures more precise than ever before. Originally developed for brain surgery, this advanced technology has been adapted for spinal procedures, giving spine surgeons a new way to visualize and perform complex surgeries, according to Dr. Steinberger.

AR works by combining detailed CT or magnetic resonance imaging (MRI) scans with an immersive virtual environment. Surgeons can use this technology to plan and simulate surgeries with significantly improved accuracy, seeing vital structures like blood vessels and nerves in real time.

“By overlaying these virtual images onto the actual surgical site through AR headsets, surgeons can guide their instruments with unmatched precision, leading to safer surgeries and better outcomes for patients,” says Dr. Steinberger.

Minimally Invasive Approaches to Improve Accuracy, Safety, and Outcomes

At the heart of Mount Sinai Spine’s approach is a dedication to minimally invasive spine surgery, where precision and patient safety come together. These techniques minimize tissue damage and shorten recovery times, and when combined with advanced robotic technologies like machine learning and AR, they further reduce the risks typically associated with traditional open surgeries.

Predicting the Best Surgical Outcomes

“Looking forward, the fusion of robotics and augmented reality in spine surgery is set to bring even more breakthroughs,” says Dr. Steinberger. “The research our team is conducting on AI algorithms that predict surgical outcomes highlights Mount Sinai’s dedication to advancing technology and enhancing patient care.”

New Mount Sinai Express Care-Queens Offers Expert Care in a Modern Facility, Expanding Services for the Community

Wendy Chung, MD, is shown with a patient at the new Mount Sinai Express Care-Queens.

Mount Sinai Queens has opened Mount Sinai Express Care-Queens, a new facility specifically designed to enhance the overall experience for patients looking to receive fast, efficient, and expert care for minor illnesses and injuries.

Located on the first floor of Mount Sinai Queens-Crescent Street, the service will build on the hospital’s vision to transform care for all residents across Queens and beyond.

The modern facility will offer walk-in services for all types of conditions, such as colds, flu, sprains, skin rashes, minor cuts and lacerations, and certain types of infections.

Patients who typically use the Emergency Department for these conditions will find shorter wait times and faster service at Mount Sinai Express Care-Queens. However, if further care is needed, the Emergency Department at Mount Sinai Queens is located across the street from Express Care, so patients do not need to travel far to receive the care that they would need after initial evaluation.

“Mount Sinai Express Care-Queens is backed by a network of experts from across the Health System that is conducive to optimizing the way we care for our patients,” says Ugo Ezenkwele, MD, MPH, Chief of Emergency Medicine at Mount Sinai Queens and Professor of Emergency Medicine at the Icahn School of Medicine at Mount Sinai. “We all get sick and need to have access to walk-in services and get the help we need as easily and quickly as possible, and this facility will fulfill a need in the community making residents feel more empowered in taking care of their health and safety.”

With five exam rooms for providing care, the location also offers testing for COVID-19, influenza, RSV, strep throat, and urinary tract infections, along with a glucometer for glucose testing, and a separate X-ray room. The new facility is the latest in several improvements at Mount Sinai Queens, whose mission is to provide compassionate, innovative care to the diverse patient community throughout the borough.

“The opening of Mount Sinai Express Care-Queens is a game changer for our hospital,” says Cameron R. Hernandez, MD, Executive Director and Chief Operating Officer at Mount Sinai Queens. “The new facility is among several projects to improve the full range of care for our patients, and we are thrilled to expand our services to better serve our community.”

Mount Sinai Express Care-Queens will accept all insurance plans; walk-ins are welcome and no appointments are necessary. Patients can also expect easy referrals to Mount Sinai specialists if you need additional, less-urgent care, as well as seamless access to medical records via MyMountSinai.

Are Women Who Drink More at Risk Than Men?

There are many areas where women and men face different health and medical issues. Now there is evidence that one area where they may differ is in a key part of our culture: how they respond to consuming alcoholic beverages.

For example, according to a recent study published in JAMA Health Forum, alcohol-related health issues rose faster among women than men during the pandemic. And surprisingly, women ages 40 to 64 experienced the fastest rate of increase. Another recent study found that women who binge drink are more likely to develop heart disease.

Timothy Brennan, MD, MPH

In this Q&A, Timothy Brennan, MD, MPH, Chief of Clinical Services for the Addiction Institute of Mount Sinai, discusses some of the ways alcohol can be harmful, including how alcohol can affect women differently than men and what you can do if you think you may have a drinking problem.

Why do women and men respond differently to alcohol?

People born biologically female or born with two X chromosomes, have a higher percentage of body fat and a lower percentage of water on average compared to men of the same weight. Alcohol is water soluble. So, if you’ve got a lower percentage of water, the alcohol concentration in a woman is higher after consumption of the same quantity of alcohol.

Here’s a scenario to illustrate: a biological XX person and biological XY person who have the same weight each consume three 12-ounce beers. The biological XX person will have a higher blood alcohol concentration compared to the other person and is therefore more impaired.

There’s also a difference in the way that women process alcohol. There’s an enzyme in our livers called alcohol dehydrogenase (ADH), that’s responsible for metabolizing alcohol in our bodies. Women have lower levels of ADH, meaning they have less ability to metabolize that alcohol. So bottom line, the alcohol hangs around longer and exerts more of an effect on women.

What amount is considered safe for a woman to drink?

Our understanding is evolving quickly, but what we now know is, no alcohol is best. Alcohol simply does not appear to convey any health benefit, whatsoever. There used to be some belief that drinking certain types of alcohol, red wine, for example, might lower your risk of cardiovascular disease. That doesn’t seem to be the case anymore. Different countries have looked at this question differently. The Canadian government has been much more emphatic than the United States that no alcohol is best.

However, if we’re defining “safe” as not being at risk to develop an alcohol use disorder, then we can look to the National Institute on Alcohol Abuse and Alcoholism for some general guidelines. They recommend that women have no more than seven drinks per week and no more than three drinks on any one day. By comparison, their recommendation for men is no more than 14 drinks per week and no more than four drinks on a single day. That means no more than a drink a day for a woman, which might strike the lay person as pretty low.

Isn’t it hard to limit drinks when we regard alcohol as a social lubricant and ingrained in our society?

Alcohol is pervasive in our cultures and in our social interactions. It’s ritualized across a variety of our holidays and traditions. It’s part of our everyday vernacular. It’s hard to even ask someone to do something in the evening without drinking being implied. Happy hour is a big component of our recreation.

But alcohol is technically a neurotoxin, which means that it is destructive to nerve tissue. I heard someone suggest that instead of using the term “alcohol,” we should use the term “neurotoxin.” It’s a provocative thought, but imagine someone saying, “Hey, would you like to get a couple neurotoxic beverages after work?” The response would most likely be, “Not really.” Just the way we talk about alcohol is very interesting.

A recent study found that women ages 40 to 64 were the fastest growing segment of people with alcohol related health problems during the pandemic. Why is that?

Most likely a lot of factors are involved. First, there’s the anxiety of society as a whole with the pandemic, so people turn to what they think are anxiety relieving products. However, the anxiety-relieving effects of alcohol diminish over time and actually promote anxiety. Someone may say, “Well, my wine is the only thing that helps,” and it becomes the thing that hurts the most with their anxiety in the long run. But on top of that, women tend to be responsible for the family, have the increased stress of children at home, and are managing an entirely new routine.

Plus, our social norms are that you really couldn’t drink on the job for the most part. But if you’re suddenly working at home, how would the boss know if you grab that glass of wine at 3 pm versus 6 pm? Nobody has any idea what you’re doing. And the normalization of drinking at home has been promoted with the advent of Zoom happy hours and social media memes.

Why is it important to discuss the health effects of alcohol?

It’s hard to find an organ system that’s not affected by alcohol. Classic examples that we talk about start off with the liver and liver damage. Types of liver damage can vary from what is called a fatty liver and advance to alcoholic hepatitis or alcoholic fibrosis. It can progress all the way to cirrhosis and liver failure, when the person will need a transplant.

Cardiovascular issues are pervasive among people who are heavy drinkers. Not only does it promote hypertension and high blood pressure, but heavy drinking also weakens the heart muscle and promotes arrhythmia, or irregular heartbeat, and stroke.

The gastrointestinal system or GI system can be irritated and develop ulcers or GI bleeds. The pancreas can frequently be acutely inflamed with alcohol and oftentimes people can develop pancreatitis. Alcohol is not safe for our brain, and long-term alcohol use can lead to cognitive impairment. It affects our psychiatric health and emotional health in many ways. Heavy alcohol use can interrupt our ability to metabolize certain vitamins and minerals such that people can develop chronic dementia. And alcohol can promote a variety of cancers. The way alcohol affects our body is very profound.

What is the difference between a heavy drinker and an alcoholic?

When we talk about alcoholism, the clinical term we use is alcohol use disorder. That’s a disease that’s been codified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, or DSM-5. Alcohol use disorder is diagnosed by 11 different criteria. It’s not something you can diagnose with a blood test. If you’ve got two to three criteria, it’s mild. If you’ve got four to five, it’s moderate. If you’ve got more than five, that’s considered a severe alcohol use disorder. Heavy drinking is not defined in the DSM-5. But the guidelines from the National Institute on Alcohol Abuse and Alcoholism we discussed earlier define low risk drinking to high-risk drinking based on the number of drinks consumed in a week. Let’s say for example, a biological female has more than seven drinks per week. But a clinician goes through that DSM-5 criteria with them, and they have none of criteria. You can’t diagnose them with an alcohol use disorder. You wouldn’t call them an alcoholic, but technically, they’re a high-risk drinker. And I think it’s reasonable to classify high risk and heavy drinkers in the same way.

Now that the pandemic is over, would you expect less drinking-related health concerns?

It’s well established in our field that once a substance use disorder takes hold, it does not go away by simply changing one factor in our environment. Alcohol hijacks the reward pathway in our central nervous system. It’s very hard to break that cycle, without any treatment and without any actual abstinence.

What should people do if they think they have a problem with alcohol?

First, there are some patient-facing websites that allow a person to quantify their alcohol use and explore it. The National Institute of Alcohol Abuse and Alcoholism has a lot of great information and interactive tools. I also encourage people to talk to their doctor. Often, people don’t realize the damage alcohol is doing to their body. And they may be self-medicating because of some other issue, like struggling with sleep or anxiety. And revealing that to their doctor can address the primary issue.

If you think you have an alcohol use disorder, I encourage people to check out a meeting of Alcoholics Anonymous. You don’t need to be an alcoholic to go to an AA meeting—there are Open Meetings where anyone can attend. And if you determine that you do have an alcohol use disorder, I always recommend that people get formal addiction treatment. And by that, I mean finding someone who is board-certified in addiction medicine. I trained in pediatrics, and then followed that with an addiction medicine fellowship. Unlike addiction psychiatry, addiction medicine is a multi-specialty subspecialty so there are a lot of different paths into it. Mine was pediatrics, but others might be internal medicine or family medicine. The good news is, there is a lot of help and resources for people seeking help.

Pin It on Pinterest